Form 10-Q · Quarterly report
Textron 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0000217346
- Accession no.
- 0000217346-26-000044
Summary
Textron reported third-quarter 2026 revenues of $3.75 billion, up 4% from a year earlier, and first-nine-month revenues of $11.27 billion, up 6%, as higher Textron Aviation and Textron Systems revenues offset lower Bell revenues. Total backlog was $19.05 billion as of October 3, 2026, compared with $18.82 billion at January 3, 2026.
Key points
- Q3 2026 revenues rose 4% to $3.751 billion; first-nine-month revenues rose 6% to $11.273 billion.
- Textron Aviation Q3 revenues rose 14% to $1.680 billion, while Bell revenues fell $93 million on lower military aircraft and support programs and commercial revenues.
- Total backlog increased to $19.048 billion as of October 3, 2026, from $18.823 billion at January 3, 2026.
- The effective tax rate was 16.1% in Q3 2026 versus 25.6% in Q3 2025, and R&D costs decreased 7% in the quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations Consolidated Results of Operations Three Months Ended Nine Months Ended (Dollars in millions) October 3, 2026 September 27, 2025 % Change October 3, 2026 September 27, 2025 % Change Revenues $ 3,751 $ 3,602 4% $ 11,273 $ 10,624 6% Cost of sales 3,086 2,948 5% 9,242 8,627 7% Gross margin as a % of Manufacturing revenues 17.4% 17.6% 17.7% 18.4% Research and development costs $ 110 $ 118 (7)% $ 346 $ 387 (11)% Selling and administrative expense 271 257 5% 903 858 5% Interest expense, net 32 30 7% 99 90 10% Special charges — — —% — 4 (100)% Non-service components of pension and postretirement income…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.